FF:10424-106D1: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{f5samples | {{f5samples | ||
| | |F5samples= | ||
| | |ancestors_in_anatomy_facet= | ||
|ancestors_in_cell_lineage_facet= | |ancestors_in_cell_lineage_facet= | ||
|ancestors_in_disease_facet=DOID:0050686,DOID:0060058,DOID:0060083,DOID:14566,DOID:162,DOID:2531,DOID:4 | |ancestors_in_disease_facet=DOID:0050686,DOID:0060058,DOID:0060083,DOID:14566,DOID:162,DOID:2531,DOID:4 | ||
| | |comment= | ||
|created_by= | |||
|creation_date= | |||
|def= | |||
|fonse_cell_line=FF:0100104 | |fonse_cell_line=FF:0100104 | ||
|fonse_cell_line_closure=FF:0100104 | |fonse_cell_line_closure=FF:0100104 | ||
Line 66: | Line 34: | ||
|fonse_treatment= | |fonse_treatment= | ||
|fonse_treatment_closure= | |fonse_treatment_closure= | ||
|has_quality= | |has_quality= | ||
|id=FF:10424-106D1 | |||
|is_a=EFO:0002091;;FF:0000003;;FF:0000210;;FF:0100104;;UBERON:0002106 | |is_a=EFO:0002091;;FF:0000003;;FF:0000210;;FF:0100104;;UBERON:0002106 | ||
|name=splenic lymphoma with villous lymphocytes cell line:SLVL | |||
|namespace=FANTOM5 | |namespace=FANTOM5 | ||
|part_of= | |part_of= | ||
|profile_cagescan=NCig10068,,, | |||
|profile_hcage=CNhs10741,LSID692,release008,COMPLETED | |||
|profile_rnaseq=,,, | |||
|profile_srnaseq=,,, | |||
|rna_box=106 | |||
|rna_catalog_number= | |||
|rna_concentration=2.31571 | |||
|rna_extraction_protocol=OP-RNA-extraction-totalRNA-miRNeasy_Mini-v1.0 | |||
|rna_lot_number= | |||
|rna_od260/230=2.08 | |||
|rna_od260/280=2.07 | |||
|rna_position=D1 | |||
|rna_rin= | |||
|rna_sample_type=total RNA | |||
|rna_tube_id=106D1 | |||
|rna_weight_ug=57.89275 | |||
|sample_age=70 | |||
|sample_cell_catalog=RCB1702 | |||
|sample_cell_line=SLVL | |||
|sample_cell_lot= | |||
|sample_cell_type=b cell | |||
|sample_collaboration=Yukio Nakamura (RIKEN BRC) | |||
|sample_company=RIKEN Bioresource centre | |||
|sample_description= | |||
|sample_dev_stage=70 year old adult | |||
|sample_disease=splenic lymphoma with villous lymphocytes | |||
|sample_donor(cell lot)= | |||
|sample_ethnicity=J | |||
|sample_experimental_condition= | |||
|sample_id=10424 | |||
|sample_note=machine failed, remainder reloaded, low amount | |||
|sample_sex=female | |||
|sample_species=Human (Homo sapiens) | |||
|sample_strain= | |||
|sample_tissue=blood | |||
|top_motifs=RORA:1.87155139459;POU5F1:1.85075531254;IRF1,2:1.77695111401;POU2F1..3:1.62967471795;RXR{A,B,G}_{NR1H2,PPAR}dimers:1.47597662173;HOX{A4,D4}:1.39705494517;CDX1,2,4:1.3936343182;NFKB1_REL_RELA:1.38611853907;HOXA9_MEIS1:1.35975411512;E2F1..5:1.35546515361;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:1.33919605896;AIRE:1.32390983299;PAX6:1.32180659995;DMAP1_NCOR{1,2}_SMARC:1.31499991893;AHR_ARNT_ARNT2:1.28569381247;FOXA2:1.2572983106;MYB:1.25075592404;NKX2-2,8:1.25020016152;YY1:1.22368811676;NFY{A,B,C}:1.22259614264;TOPORS:1.15424242647;EVI1:1.11286277634;NKX6-1,2:1.04056079423;IRF7:1.00421831559;ELF1,2,4:0.975862552422;PITX1..3:0.930742691711;ELK1,4_GABP{A,B1}:0.899534387551;HBP1_HMGB_SSRP1_UBTF:0.879367352517;VSX1,2:0.847110615549;MYOD1:0.757383521225;OCT4_SOX2{dimer}:0.741603607398;POU1F1:0.731769890311;FOXP1:0.728548183822;HIF1A:0.712221439015;CUX2:0.710739218327;ZNF143:0.697754678027;NRF1:0.687925967313;SPI1:0.678971861023;GFI1:0.67668489111;ZBTB16:0.628644575574;CDC5L:0.599554679493;NR5A1,2:0.594019253878;FOXQ1:0.562065752355;RUNX1..3:0.544286737671;ALX1:0.532029559378;SPIB:0.49941765783;bHLH_family:0.449021139462;PBX1:0.371719310294;HSF1,2:0.364640014202;FOX{F1,F2,J1}:0.361758729752;LMO2:0.353826133286;FOXP3:0.33666947221;GATA6:0.320100638993;BPTF:0.30841501609;PAX3,7:0.300143959883;ATF5_CREB3:0.289700647444;TP53:0.286022963944;RBPJ:0.242691150876;TFDP1:0.23877759807;NANOG{mouse}:0.214032716737;PAX8:0.191515642283;FOXN1:0.174188537823;NKX2-1,4:0.173518051602;SREBF1,2:0.170598218789;TEF:0.156330463429;ZNF384:0.0947005290683;HES1:0.0683156130474;PAX2:0.026388098804;RFX2..5_RFXANK_RFXAP:0.0228799328265;ZEB1:0.021423447579;SNAI1..3:0.00179941392495;ETS1,2:0.000402024460678;STAT5{A,B}:-0.0045787588071;TGIF1:-0.0150393712541;BREu{core}:-0.0216084303249;SOX{8,9,10}:-0.0433990989615;IKZF2:-0.0824035647719;PDX1:-0.116721121344;HMGA1,2:-0.120229194034;ESRRA:-0.15204097329;MEF2{A,B,C,D}:-0.16962636036;PAX4:-0.174566315732;FOSL2:-0.174812127642;POU3F1..4:-0.176235586993;HNF4A_NR2F1,2:-0.182336572774;ARID5B:-0.202628050711;SPZ1:-0.204700891922;TLX2:-0.211356345213;HAND1,2:-0.218639034932;PRRX1,2:-0.220489287264;HNF1A:-0.229807492115;SOX5:-0.245687665461;CRX:-0.252972817633;HOX{A5,B5}:-0.255993897162;EN1,2:-0.276325640807;HOX{A6,A7,B6,B7}:-0.281674657864;NFE2:-0.285190644358;ONECUT1,2:-0.285594549665;GATA4:-0.356236932201;RXRA_VDR{dimer}:-0.356554729336;FOXO1,3,4:-0.35777115143;NANOG:-0.376407046922;IKZF1:-0.408274901872;FOS_FOS{B,L1}_JUN{B,D}:-0.418970309386;CREB1:-0.432014276314;ZFP161:-0.469267967706;STAT1,3:-0.502047832013;GFI1B:-0.503023953117;SOX17:-0.508057799779;MYBL2:-0.524107613256;GCM1,2:-0.53283812287;LHX3,4:-0.544692834346;RFX1:-0.545425445337;PRDM1:-0.554549304513;CEBPA,B_DDIT3:-0.574542782979;ATF2:-0.586992865496;ATF4:-0.604958224603;LEF1_TCF7_TCF7L1,2:-0.611465160956;TAL1_TCF{3,4,12}:-0.61559379376;ALX4:-0.618538166802;FOXM1:-0.619744781448;BACH2:-0.655016968914;MYFfamily:-0.676078324599;NKX3-2:-0.677069142799;DBP:-0.678480549916;UFEwm:-0.698669833921;SOX2:-0.700413044906;RREB1:-0.713473656687;NR1H4:-0.738591379158;HLF:-0.745938049364;ADNP_IRX_SIX_ZHX:-0.767707021346;ZIC1..3:-0.775373451042;NHLH1,2:-0.798004191437;AR:-0.816442577357;SMAD1..7,9:-0.818212369741;PPARG:-0.824122411458;EP300:-0.83390118126;NFIL3:-0.854881173727;ZNF148:-0.865903434253;NFATC1..3:-0.893039825448;NKX2-3_NKX2-5:-0.916499037516;NFE2L2:-0.935835018079;FOX{I1,J2}:-0.944588577521;FOXD3:-0.964436666073;SRF:-0.976184089367;FOX{D1,D2}:-0.998633880635;KLF4:-1.00818548078;NFIX:-1.00998106408;GLI1..3:-1.01172671799;ZNF238:-1.03144078578;GZF1:-1.03611261896;MED-1{core}:-1.03822560476;MZF1:-1.047692684;NR6A1:-1.04769391698;HMX1:-1.05063534575;RXR{A,B,G}:-1.05629012615;REST:-1.0587871743;MAFB:-1.0709609013;TBP:-1.07160236168;PAX1,9:-1.07526657485;TBX4,5:-1.08085288703;NR3C1:-1.0845359461;GTF2I:-1.08886673221;POU6F1:-1.09181091181;JUN:-1.1027973207;MTE{core}:-1.12118870938;NFE2L1:-1.15165846347;GTF2A1,2:-1.15552963165;NKX3-1:-1.17786090252;TFAP4:-1.22428220421;EBF1:-1.24174421307;STAT2,4,6:-1.27455415467;ESR1:-1.28132147001;MTF1:-1.33342570408;ZBTB6:-1.34294596216;ATF6:-1.43203898877;XCPE1{core}:-1.47207399395;HIC1:-1.47218227736;MAZ:-1.48042075885;TLX1..3_NFIC{dimer}:-1.48868366134;TEAD1:-1.49183302177;EGR1..3:-1.547860579;PATZ1:-1.56785195456;PAX5:-1.59364900098;TFCP2:-1.70781198814;ZNF423:-1.7416361356;XBP1:-1.80527649019;SP1:-1.85367336127;TFAP2{A,C}:-1.92950666284;TFAP2B:-1.93788323687;FOXL1:-2.08539211116;T:-2.5274837803 | |||
}} | }} |
Revision as of 14:06, 21 March 2012
Name: | splenic lymphoma with villous lymphocytes cell line:SLVL |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs10741
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs10741
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.00799 |
10 | 10 | 0.0144 |
100 | 100 | 0.495 |
101 | 101 | 0.195 |
102 | 102 | 0.624 |
103 | 103 | 0.0876 |
104 | 104 | 0.433 |
105 | 105 | 0.675 |
106 | 106 | 0.957 |
107 | 107 | 0.717 |
108 | 108 | 0.747 |
109 | 109 | 0.0777 |
11 | 11 | 0.167 |
110 | 110 | 0.114 |
111 | 111 | 0.0149 |
112 | 112 | 0.104 |
113 | 113 | 0.671 |
114 | 114 | 0.207 |
115 | 115 | 0.623 |
116 | 116 | 0.627 |
117 | 117 | 0.0188 |
118 | 118 | 0.128 |
119 | 119 | 0.102 |
12 | 12 | 0.852 |
120 | 120 | 0.55 |
121 | 121 | 0.363 |
122 | 122 | 0.371 |
123 | 123 | 1.30856e-4 |
124 | 124 | 0.0615 |
125 | 125 | 0.67 |
126 | 126 | 0.117 |
127 | 127 | 0.509 |
128 | 128 | 0.347 |
129 | 129 | 0.39 |
13 | 13 | 0.0635 |
130 | 130 | 0.995 |
131 | 131 | 0.221 |
132 | 132 | 0.572 |
133 | 133 | 0.587 |
134 | 134 | 0.612 |
135 | 135 | 0.571 |
136 | 136 | 0.281 |
137 | 137 | 0.171 |
138 | 138 | 0.857 |
139 | 139 | 0.218 |
14 | 14 | 0.692 |
140 | 140 | 0.193 |
141 | 141 | 0.0628 |
142 | 142 | 0.65 |
143 | 143 | 0.304 |
144 | 144 | 0.516 |
145 | 145 | 0.179 |
146 | 146 | 0.426 |
147 | 147 | 0.0525 |
148 | 148 | 0.115 |
149 | 149 | 0.529 |
15 | 15 | 0.0523 |
150 | 150 | 0.972 |
151 | 151 | 0.924 |
152 | 152 | 0.0633 |
153 | 153 | 0.207 |
154 | 154 | 0.905 |
155 | 155 | 0.0875 |
156 | 156 | 0.959 |
157 | 157 | 0.247 |
158 | 158 | 0.315 |
159 | 159 | 0.337 |
16 | 16 | 0.785 |
160 | 160 | 0.136 |
161 | 161 | 0.00795 |
162 | 162 | 0.975 |
163 | 163 | 0.761 |
164 | 164 | 0.208 |
165 | 165 | 0.788 |
166 | 166 | 0.265 |
167 | 167 | 0.396 |
168 | 168 | 0.844 |
169 | 169 | 0.722 |
17 | 17 | 0.546 |
18 | 18 | 0.466 |
19 | 19 | 0.949 |
2 | 2 | 0.498 |
20 | 20 | 0.369 |
21 | 21 | 0.161 |
22 | 22 | 0.986 |
23 | 23 | 0.325 |
24 | 24 | 0.174 |
25 | 25 | 0.188 |
26 | 26 | 0.0839 |
27 | 27 | 0.742 |
28 | 28 | 0.696 |
29 | 29 | 0.0206 |
3 | 3 | 0.0885 |
30 | 30 | 0.0791 |
31 | 31 | 0.765 |
32 | 32 | 0.733 |
33 | 33 | 0.741 |
34 | 34 | 0.632 |
35 | 35 | 0.126 |
36 | 36 | 0.0175 |
37 | 37 | 0.329 |
38 | 38 | 0.335 |
39 | 39 | 0.547 |
4 | 4 | 0.665 |
40 | 40 | 0.387 |
41 | 41 | 0.653 |
42 | 42 | 0.114 |
43 | 43 | 0.282 |
44 | 44 | 0.167 |
45 | 45 | 0.409 |
46 | 46 | 0.19 |
47 | 47 | 0.0486 |
48 | 48 | 0.0903 |
49 | 49 | 0.16 |
5 | 5 | 0.644 |
50 | 50 | 0.952 |
51 | 51 | 0.671 |
52 | 52 | 0.428 |
53 | 53 | 0.35 |
54 | 54 | 0.767 |
55 | 55 | 0.957 |
56 | 56 | 0.75 |
57 | 57 | 0.081 |
58 | 58 | 0.136 |
59 | 59 | 0.662 |
6 | 6 | 0.886 |
60 | 60 | 0.814 |
61 | 61 | 0.0826 |
62 | 62 | 0.122 |
63 | 63 | 0.548 |
64 | 64 | 0.267 |
65 | 65 | 0.799 |
66 | 66 | 0.1 |
67 | 67 | 0.584 |
68 | 68 | 0.335 |
69 | 69 | 0.794 |
7 | 7 | 0.108 |
70 | 70 | 0.443 |
71 | 71 | 0.0238 |
72 | 72 | 0.264 |
73 | 73 | 0.96 |
74 | 74 | 0.551 |
75 | 75 | 0.00566 |
76 | 76 | 0.26 |
77 | 77 | 0.846 |
78 | 78 | 0.319 |
79 | 79 | 0.541 |
8 | 8 | 0.173 |
80 | 80 | 0.376 |
81 | 81 | 0.0625 |
82 | 82 | 0.867 |
83 | 83 | 0.64 |
84 | 84 | 0.215 |
85 | 85 | 0.877 |
86 | 86 | 0.24 |
87 | 87 | 0.319 |
88 | 88 | 0.794 |
89 | 89 | 0.668 |
9 | 9 | 0.639 |
90 | 90 | 0.0153 |
91 | 91 | 0.89 |
92 | 92 | 0.838 |
93 | 93 | 0.877 |
94 | 94 | 0.493 |
95 | 95 | 0.0446 |
96 | 96 | 0.24 |
97 | 97 | 0.271 |
98 | 98 | 0.374 |
99 | 99 | 0.23 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs10741
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000003 cell line sample
FF:0000210 human sample
FF:0100104 lymphoma cell line sample
UBERON:0002106 spleen
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
DOID: Disease
0050686 (organ system cancer)
0060058 (lymphoma)
0060083 (immune system cancer)
14566 (disease of cellular proliferation)
162 (cancer)
2531 (hematologic cancer)
4 (disease)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA